103 Carnegie Center, Suite 103
Princeton, NJ 08540,USA
(609) 799-0050
(609) 497-9695





Vilma Petrin, M.D.
Vice President, Drug Safety and Pharmacovigilance

Dr. Petrin has more than 25 years of medical experience, including over 17 years in Drug Safety and Pharmacovigilance. Prior to joining PRS, she was the Director of Drug Safety and Pharmacovigilance at PharmaNet Inc. in Princeton, New Jersey. There she directed the US Regulatory Safety Group and provided input on the overall processes and policies of the review and processing of safety information. Vilma was also responsible for starting their pharmacovigilance activities and was responsible for the safety assessments of investigational and marketed products.

Before joining PharmaNet, Vilma served as the Associate Director of Drug Safety and Pharmacovigilance at Bristol-Myers Squibb where she performed medical surveillance of central nervous system, cardiovascular, dermatological and endocrine products (over 60 products). She monitored adverse event cases and contributed medical considerations to adverse affect case processing, reviewed safety data to detect emerging trends,prepared periodic safety update reports and expert reports and participated in labeling activities.

At PRS Inc., Vilma is responsible for building and directing the world-wide operations of the Regulatory Safety Group. She is responsible for management drug safety and pharmacovigilance activities, and provides consulting on pharmacovigilance issues, offers pharmacovigilance trainings and conducts audits of pharmacovigilance systems.

She received her medical degree from the University of Ljubljana Medical School in Ljubljana, Slovenia and her Postdoctoral Degree in Public Health from the University of Ljubljana.


All rights reserved.